|
Mane event: Recombination in lion feline immunodeficiency virus (EurekAlert!)
Parts of feline immunodeficiency virus (FIV) isolated from wild lions have undergone substantial genetic recombination, says research published in the online open access journal BMC Genomics.
(Feb 4, 2008)
GenomeQuest, Inc. Launches 'DrugBank Pro' Database, With Six-Month Advance DrugBank Data And Exclusive IND Information (PharmaceuticalOnline)
GenomeQuest, Inc., the leader in genomic search, recently announced the launch of "DrugBank Pro", an exclusive database of sequence and annotation information on all approved drugs, their targets and metabolizing enzymes located in the University of Alberta's DrugBank database, six months prior to publication, along with full access to its non-public Investigational New Drug (IND) database of ...
(Feb 5, 2008)
Team led by Indian compiles online protein encyclopaedia (Calcutta News)
An international team led by an Indian biologist has pioneered an online encyclopaedia of human proteins that will help accelerate biomedical research and drug discovery.
(Feb 5, 2008)
Mane event: Recombination in lion feline immunodeficiency virus (PhysOrg)
Parts of feline immunodeficiency virus (FIV) isolated from wild lions have undergone substantial genetic recombination, says research published in the online open access journal BMC Genomics. The sequencing of the two full FIV genomes of different lion subtypes shows the importance of whole-genome analysis in understanding complex genetic events. These findings will be relevant to big cat ...
(Feb 5, 2008)
Today's Research: Tomorrow's Health: Experimental Biology April 5-9 2008 (Medical News Today)
More than 13,000 biological and biomedical scientists will gather for the Experimental Biology 2008 meeting in San Diego April 5-9.The theme of the annual meeting, now in its 18th year, is "Today's Research: Tomorrow's Health." Thousands of lectures, symposia, research presentations and exhibits have been selected because of their potential to shape future and current clinical advances.
(Feb 5, 2008)
Recombination In Lion Feline Immunodeficiency Virus (Medical News Today)
Parts of feline immunodeficiency virus (FIV) isolated from wild lions have undergone substantial genetic recombination, says research published in the online open access journal BMC Genomics. The sequencing of the two full FIV genomes of different lion subtypes shows the importance of whole-genome analysis in understanding complex genetic events.
(Feb 5, 2008)
Cell Signaling Technology Announces Continued PhosphoScan(R) Proteomics Research Project with Bristol-Myers Squibb for ... (Business Wire via Yahoo! Finance)
DANVERS, Mass.----Cell Signaling Technology, Inc. announced today the continuation of a research agreement with Bristol-Myers Squibb Company under which CST will employ its patented PhosphoScan® technology in the cell and tumor phospho-profiling of a Bristol-Myers Squibb small-molecule kinase inhibitor.
(Feb 5, 2008)
Reverse Engineering Biological Networks Attempts a Systematic Evaluation of Reverse Engineering Methods (Business Wire via Yahoo! Finance)
DUBLIN, Ireland----Research and Markets has announced the addition of "Reverse Engineering Biological Networks" to their offering.
(Feb 5, 2008)
GSK Extends GeneGo License and Adds New Products (PR Newswire via Yahoo! Finance)
GeneGo, Inc., the leading systems biology tools company, announced today that GSK has extended their licensing agreement with GeneGo and have added additional capability.
(Feb 5, 2008)
SGI to integrate eXludus software into cluster offering (PR Newswire via Yahoo! Finance)
eXludus Technologies, the leading developer of multi-core system capacity management, virtualization and provisioning solutions, today announced a reseller relationship with SGI , a leader in high-performance computing.
(Feb 5, 2008)
Strategic Diagnostics to Present at Roth Capital Partners' 20th Annual OC Growth Stock Conference February 20 (Centre Daily Times)
Strategic Diagnostics Inc. (Nasdaq:SDIX) - a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, environmental and life science applications, announced today that its President and Chief Executive Officer, Matthew Knight, and the Company's Chief Financial Officer, Stan Fronczkowski, will present at Roth Capital Partners' 20th Annual Growth ...
(Feb 5, 2008)
The Handbook of Tuberculosis: Molecular Biology and Biochemistry is an Essential Resource to Molecular and Cell ... (Centre Daily Times)
Research and Markets (http://www.researchandmarkets has announced the addition of Handbook of Tuberculosis: Molecular Biology and Biochemistry to their offering.
(Feb 5, 2008)
News From The American Chemical Society (Medical News Today)
Iodized table salt may be low in iodine, raising health concernsAmid concern that people in the United States are consuming inadequate amounts of iodine, scientists in Texas have found that 53 percent of iodized salt samples contained less than the U.S. Food and Drug Administration (FDA) recommended level of this key nutrient.
(Feb 5, 2008)
4th Biomarker Workshop at the NMI in Reutlingen: Another success (uniprotokolle)
The Biomarker Workshop held at the NMI in late January has become a fixed date for a growing number of proteomics researchers. With an attendance of 130, this year's workshop exceeded all previous ones.
(Feb 5, 2008)
Disrupted genetic regulation causes common disturbance in metabolism of fat (EurekAlert!)
The disease familial combined hyperlipidemia (FCH) is a common cause of disturbed metabolism of fat and early heart attacks.
(Feb 5, 2008)
Comparative Genomics Reveals Differences in Lion FIV Strains (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.
(Feb 5, 2008)
Disrupted genetic regulation causes common disturbance in metabolism of fat (PhysOrg)
The disease familial combined hyperlipidemia (FCH) is a common cause of disturbed metabolism of fat and early heart attacks. Uppsala University scientists have now developed a pioneering method and can show for the first time what genes are regulated by the gene USF1, which is known to cause the disease. These findings are being presented today in the leading journal Genome Research.
(Feb 5, 2008)
SGI to Integrate eXludus (Byte and Switch)
MONTREAL -- eXludus Technologies, the leading developer of multi-core system capacity management, virtualization and provisioning solutions, today announced a reseller relationship with SGI (NASDAQ: SGIC - message board ), a leader in high-performance computing.
(Feb 5, 2008)
Small caps round-up: Proteome, MKM, Plethora, Toluna, Twenty (ShareCast via Yahoo! UK & Ireland Finance)
Applied proteomics firm Proteome Sciences said it is not aware of any reason behind its recent share price increase.
(Feb 5, 2008)
SGI to Intergrate eXludus Software Into Cluster Offering (SYS-CON Media)
eXludus, a developer of multi-core system capacity management, virtualization and provisioning solutions, announced a reseller relationship with SGI. SGI will embed eXludus Grid Optimizer software in its new BioCluster solution, developed specifically for the life sciences market.
(Feb 5, 2008)
Invitrogen, Agilent Technologies Settle Multiple Patent Litigations (Business Wire via Yahoo! Finance)
CARLSBAD, Calif., & SANTA CLARA, Calif.----Invitrogen Corporation and Agilent Technologies have jointly announced a confidential settlement of multiple patent litigations pending between the two companies.
(Feb 5, 2008)
Invitrogen Announces Fourth Quarter and Full Year 2007 Results (Finanzen.net)
Invitrogen Corporation (Nasdaq:IVGN) today announced results for its fourth quarter and full year ended December 31, 2007. Revenues for the fourth quarter were $336 million, resulting in full year sales of $1,282 million, an increase ...
(Feb 5, 2008)
Invitrogen, Agilent Technologies Settle Multiple Patent Litigations (wallstreet:online AG)
Invitrogen Corporation and Agilent Technologies have jointly announced a confidential settlement of
(Feb 5, 2008)
Researchers identify a worldwide-distributed clone of bacteria responsible for Legionnaire's disease (EurekAlert!)
Wednesday, February 6, 2008 – A study published online today in Genome Research ( www.genome.org ) describes new insights into Legionella pneumophila , the bacteria responsible for most cases of Legionnaires’ disease.
(Feb 5, 2008)
Invitrogen Announces Fourth Quarter and Full Year 2007 Results (Centre Daily Times)
Invitrogen Corporation (Nasdaq:IVGN) today announced results for its fourth quarter and full year ended December 31, 2007. Revenues for the fourth quarter were $336 million, resulting in full year sales of $1,282 million, an increase of 11 percent over the $1,151 million reported for 2006.
(Feb 5, 2008)
Invitrogen, Agilent Technologies Settle Multiple Patent Litigations (Centre Daily Times)
Invitrogen Corporation and Agilent Technologies have jointly announced a confidential settlement of multiple patent litigations pending between the two companies. The settlement resolves three patent infringement lawsuits between Invitrogen and Stratagene, Inc. Agilent acquired Stratagene in 2007.
(Feb 5, 2008)
Environmental Epigenetics Has Potential For Preventing And Treating Disease (Science Daily)
New research on environmental influences on health and disease has begun to shed light on why genetically identical individuals demonstrate different characteristics, such as susceptibility to disease. Scientists have found that environmental exposure to nutritional, chemical and physical factors can alter the epigenome. Literally meaning "above the genome," the epigenome refers to differences ...
(Feb 5, 2008)
$20 million Arizona venture fund dedicated to biosciences (BizJournals)
A consortium of biotechnology and investment professionals have partnered to create Arizona's first venture capital firm dedicated to early-stage bioscience companies.
(Feb 6, 2008)
Researchers Identify A Worldwide-distributed Clone Of Bacteria Responsible For Legionnaire's Disease (Medical News Today)
A study published online today in Genome Research describes new insights into Legionella pneumophila, the bacteria responsible for most cases of Legionnaires' disease. This report investigates the genetic background of L. pneumophila, provides clues to the evolution and emergence of this pathogen, and describes the identification of a worldwide-distributed epidemic clone.
(Feb 6, 2008)
$20 million fund will boost bioscience companies (The Arizona Republic)
Arizona technology and business leaders have established a $20 million venture-capital fund that will target early-stage bioscience companies seeking a financial boost to develop their ideas.
(Feb 6, 2008)
Bioengineering Bugs to Make Fuel (Portfolio.com via Yahoo! Finance)
Maverick scientist Craig Venter announces that his team has created the largest manmade molecule in history—a chromosome that may be the key to building organisms that can make fuel, and much more.
(Feb 6, 2008)
Bioengineering Bugs to Make Fuel (Portfolio.com via Yahoo! Finance)
Maverick scientist Craig Venter announces that his team has created the largest manmade molecule in history—a chromosome that may be the key to building organisms that can make fuel, and much more.
(Feb 6, 2008)
Life Sciences IT Vendors Enjoy Exciting Growth Potential in Europe (Centre Daily Times)
Life sciences companies across Europe are looking for an extensive mix of services and solutions. Accordingly, service opportunities in life sciences IT (LSIT) are set to expand considerably as life sciences gear up to tackle bioinformatics and a host of key technology solutions.
(Feb 6, 2008)
Applied Biosystems Expands Line of Labeling Chemistry Reagents to Help Improve Proteomics Research (Business Wire via Yahoo! Finance)
FOSTER CITY, Calif.----Applied Biosystems , an Applera Corporation business, today announced an expansion of its line of labeling chemistry reagents used for proteomics research in academic and biopharmaceutical laboratories.
(Feb 6, 2008)
Applied Biosystems Expands Line of Labeling Chemistry Reagents to Help Improve Proteomics Research (Centre Daily Times)
Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced an expansion of its line of labeling chemistry reagents used for proteomics research in academic and biopharmaceutical laboratories. The new 8plex version of Applied Biosystems' iTRAQ(R) reagents is designed to double the existing capacity for discovering proteins and comparing protein levels between biological ...
(Feb 6, 2008)
Znomics Advances Drug Discovery Efforts in Zebrafish With Launch of New Human Disease Library (PrimeNewswire via Yahoo! Finance)
PORTLAND, Ore., Feb. 6, 2008 -- Znomics, Inc. , a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, today announced it has achieved mutations in 193 key genes, representing nearly 50 percent of the known "druggable" disease genes.
(Feb 6, 2008)
Common Disturbance In Metabolism Of Fat Caused By Disrupted Genetic Regulation (Medical News Today)
The disease familial combined hyperlipidemia (FCH) is a common cause of disturbed metabolism of fat and early heart attacks. Uppsala University scientists have now developed a pioneering method and can show for the first time what genes are regulated by the gene USF1, which is known to cause the disease. These findings are being presented today in the leading journal Genome Research.
(Feb 6, 2008)
Journal Of Cardiovascular Translational Research Will Bridge Gap Between Biomedical Research And Clinical Medicine (Medical News Today)
Springer and the International Society for Cardiovascular Translational Research (ISCTR) are founding a new, quarterly biomedical publication called the Journal of Cardiovascular Translational Research (JCTR).
(Feb 6, 2008)
U of T gets $23.3M in tech funding (CBC Toronto)
The University of Toronto will get $23.3 million in provincial funding for four new technology projects, including to prevent infectious diseases using nanotechnology and to place wireless internet services in rural communities, the government said Tuesday.
(Feb 6, 2008)
Plant DNA 'barcode' boosts biodiversity research (SciDev.net)
Researchers have found a section of plant DNA that could be used as the universal 'barcode' to identify flowering plants, aiding biodiversity research.
(Feb 6, 2008)
InforSense and BioWisdom to Integrate Analytic Technologies for Bioinformatics (Marketwire via Yahoo! Finance)
InforSense Ltd., the leading provider of embedded enterprise intelligence, today announced that it will integrate BioWisdom's SRS bioinformatics software with InforSense's workflow analytics platform, enabling customers to automate and improve their bioinformatics analysis.
(Feb 6, 2008)
Illumina Sequences the First African Human Genome (Business Wire via Yahoo! Finance)
SAN DIEGO----Illumina, Inc. today announced that scientists at the Company have sequenced the genome of an anonymous African male , using the Genome Analyzer. Sequencing of this HapMap sample was conducted internally and marks the first human genome sequence generated exclusively with paired reads of 35 to 50 bases in length.
(Feb 6, 2008)
Illumina Sequences the First African Human Genome (wallstreet:online AG)
Illumina, Inc. (7884;NASDAQ:ILMN) today announced that scientists at the Company have sequenced the genome
(Feb 6, 2008)
Genetic-mapping unveiled to test infectious diseases (USA Today)
A team of scientists unveiled a new playbook Wednesday in the fight against infectious disease outbreaks: Genetic-mapping by computers to find bugs that slip past all other modern medical tests.
(Feb 6, 2008)
Global Heart Experts Gather in San Diego February 9th--10th (Newswise)
More than thirty international experts from all fields of cardiovascular research will gather in San Diego on February 9 and 10, 2008 to share the latest advances in the fields of cellular therapy and genomics in the treatment of cardiovascular disease.
(Feb 6, 2008)
Scientists confirm new virus responsible for deaths of transplant recipients in Australia (PhysOrg)
In the first application of high throughput DNA sequencing technology to investigate an infectious disease outbreak, scientists from Columbia University Mailman School of Public Health, the Victorian Infectious Diseases Reference Laboratory (VIRDL) in Melbourne, Australia, the Centers for Disease Control and 454 Life Sciences link the discovery of a new arenavirus to the deaths of three ...
(Feb 6, 2008)
New technology adds value to dairy (Scoop.co.nz)
Scientists are creating new economic opportunities in our dairy industry, Pete Hodgson, Minister of Research Science and Technology said during a visit to AgResearch campus near Hamilton today.
(Feb 7, 2008)
State funds non-SUS schools despite budget cuts (University of South Florida Oracle)
Some University administrators and local politicians are upset with Gov. Charlie Crist's decision to grant $140 million to one private university and another out-of-state university.
(Feb 7, 2008)
GSK extends licensing agreement with GeneGo (Pharmaceutical Business Review)
GlaxoSmithKline has extended its licensing agreement with GeneGo and has added additional capability. This agreement will provide GlaxoSmithKline researchers in bioinformatics, R&D and clinical studies with global access to MetaCore, MapEditor and MetaBase.
(Feb 7, 2008)
Powerful Tool For Pathogen Discovery Enables Improvements In Screening For Transplant Safety (Medical News Today)
In the first application of high throughput DNA sequencing technology to investigate an infectious disease outbreak, scientists from Columbia University Mailman School of Public Health, the Victorian Infectious Diseases Reference Laboratory (VIRDL) in Melbourne, Australia, the Centers for Disease Con
(Feb 7, 2008)
|
